healthfinch, a Madison-based healthcare IT startup, has secured $6 million in funding led by Adams Street Partners to continue building and supporting its award-winning Charlie Practice Automation Platform. This funding brings the company’s total raised to over $17MM since it was founded in 2011.The Charlie Practice Automation Platform, developed by healthfinch, automates routine, repetitive clinical tasks in athenahealth, Epic, and Allscripts EMRs. Its refill management and visit planning
Read More
Aetion Raises $36M to Expand Evidence Analytics Platform for Value-Based Care
Aetion, a software platform company that delivers real-world analytics and evidence needed for biopharma and payers to engage in value-based care, has raised $36.4 million in Series B funding. The round was led by New Enterprise Associates (NEA) and included a new investor, Amgen Ventures, alongside existing investors Flare Capital Partners, Lakestar and Oxeon Ventures. Mohamad Makhzoumi of NEA will join the Aetion board of directors.With the addition of the $36 million, Aetion has raised a
Read More
hc1.com Raises $7M to Further Expansion into Healthcare CRM Market
hc1.com, a Indianapolis, IN-based provider of healthcare relationship management, today announced it has raised $7 million in new Series B capital led by private equity firm Health Cloud Capital and included participation from Elevate Ventures, a long-time investor in hc1.com. The latest round of funding enables the company to continue its aggressive expansion within the healthcare CRM market, and to drive expanded adoption of its newly launched information services, including hc1
Read More
AI Nutrition Data Startup Nutrino Lands $10M to Build Largest Food Database
Nutrino, an Israeli-based digital health provider of nutrition-related data services and analytics technology, announced today the completion of its Series A round of $8 million, bringing the total raised to $10 million. The round included participation from Pereg Ventures, Nielsen Ventures and Gandyr Group joined existing investors - including the New York Angels group. The latest round of funding will be used to further develop Nutrino’s database, which collates data from millions of food
Read More
Novartis to Acquire Gene Therapy Provider AveXis for $8.7B in Cash
Novartis announced today that is has entered into an agreement to acquire AveXis, Inc., a clinical stage gene therapy company for $8.7 billion in cash. AveXis lead product candidate, AVXS-101, has potential to be first-ever one-time gene replacement therapy for spinal muscular atrophy (SMA), a disease which results in early death or lifelong disability with considerable healthcare costs. It is estimated that one out of every 6,000-10,000 children born is affected by some form of SMA.The US Food
Read More
AMA and Google Launch Healthcare Interoperability and Innovation Challenge to Foster Data Sharing
The American Medical Association (AMA) and Google are teaming up to launch the AMA Health Care Interoperability and Innovation Challenge. Sponsored by Google, the challenge aims to inspire novel examples of mobile health technology - such as wearable devices and applications - that effectively monitor and share medical data between patients and physicians to improve the management of chronic diseases.“The AMA is working to unleash a new era of patient care through its Integrated Health Model
Read More
TruSense Releases Amazon Alexa Integrated ‘Smart’ Personal Emergency Response Pendant
TruSense, a smart home monitoring solution designed for seniors, has added the first-ever smart personal emergency response (PERS) pendant to combine GPS with notification when it is not being worn. Made to alleviate caregiver worry, the pendant works in conjunction with TruSense Home, a sensor-based smart home solution. This allows for customized alerts when the user is not wearing the pendant, extending protection outside of the home.Customized alerts can notify caretakers when the wearer has
Read More
Vitra Health Nabs $45M to Reverse Type 2 Diabetes
Virta Health, a San Francisco, CA-based company delivering the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes (T2D) and other chronic metabolic diseases without the use of medications or surgery has raised a $45 million Series B funding round. THe round include participation from existing investors including Venrock, Obvious Ventures, Creandum,Caffeinated Capital, and Max Levchin’s SciFi VC, along with new investors including Founders Fund and Playground
Read More
Ferring Acquires Microbiome Platform Rebiotix
Ferring Pharmaceuticals, a research-driven, specialty biopharmaceutical group has acquired Rebiotix Inc., a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to transform the treatment of challenging diseases. This acquisition brings together two innovative healthcare companies that share a common commitment to exploring and understanding the human microbiome to develop new solutions for patients. Rebiotix’s RBX2660 is a non-antibiotic treatment in
Read More
SCI Solutions Acquires Digital Patient Engagement Company DatStat
SCI Solutions (SCI), a patient access and care coordination software company has acquired DatStat, a provider of patient engagement and digital health tools. The combination of SCI’s market-leading patient scheduling, referral management and revenue cycle software with DatStat’s digital self-service tools for pre-visit preparation, secure messaging, visit summaries and care plans, creates a complete patient access and engagement solution for patients to conveniently connect with their care teams
Read More